Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's Disease
Open accessThe DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Abstract
BACKGROUND: In cross-sectional studies, elevated plasma homocysteine levels have been associated with poor cognition and dementia. Studies of newly diagnosed dementia are required in order to establish whether the elevated homocysteine levels precede the onset of dementia or result from dementia-related nutritional and vitamin deficiencies. METHODS: A total of 1092 subjects without dementia (667 women and 425 men; mean age, 76 years) from the Framingham Study constituted our study sample. We examined the relation of the plasma total homocysteine level measured at base line and that measured eight years earlier to the risk of newly diagnosed dementia on follow-up. We used multivariable proportional-hazards regression to adjust for age, sex, apolipoprotein E genotype, vascular risk factors other than homocysteine, and plasma levels of folate and vitamins B12 and B6. RESULTS: Over a median follow-up period of eight years, dementia developed in 111 subjects, including 83 given a diagnosis of Alzheimer's disease. The multivariable-adjusted relative risk of dementia was 1.4 (95 percent confidence interval, 1.1 to 1.9) for each increase of 1 SD in the log-transformed homocysteine value either at base line or eight years earlier. The relative risk of Alzheimer's disease was 1.8 (95 percent confidence interval, 1.3 to 2.5) per increase of 1 SD at base line and 1.6 (95 percent confidence interval, 1.2 to 2.1) per increase of 1 SD eight years before base line. With a plasma homocysteine level greater than 14 micromol per liter, the risk of Alzheimer's disease nearly doubled. CONCLUSIONS: An increased plasma homocysteine level is a strong, independent risk factor for the development of dementia and Alzheimer's disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Adjudication for Alzheimer’s phenotypes was done by a committee41, comprising at least two neurologists and a neuropsychologist.”
From Clonal hematopoiesis is associated with protection from Alzheimer’s disease (2023) · cites this paper as [41]
In the citing paper
“Dementia diagnoses were made according to DSM‐IV criteria, based on longitudinal cognitive assessments, caregiver interviews, medical records, neuroimaging, and autopsy data when available.”
From Blood PCSK9 Impacts Alzheimer's Disease Risk in an APOE Genotype‐Dependent Manner: A Prospective Cohort Study (2026) · cites this paper as [18]
In the citing paper
“Overall, of the 19 selected cohort studies linking Hcy to the various cognitive outcomes, 12(63.2%) found the relationship in the hypothesized direction in the entire population that was studied and for most outcomes of interest [206,215,217,219,222-224,228,231,233-235]”
From Epidemiologic studies of modifiable factors associated with cognition and dementia: systematic review and meta-analysis (2014) · cites this paper as [206]
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Cox, D. R., & Oakes, D. (2018) · Chapman & Hall/CRC eBooks · doi:10.1201/9781315137438 · Cited by 6,234
Homocysteine and Atherothrombosis
Welch, G. N., & Loscalzo, J. (1998) · New England Journal of Medicine · doi:10.1056/nejm199804093381507 · Cited by 1,997
Vitamin Status and Intake as Primary Determinants of Homocysteinemia in an Elderly Population
Selhub, J. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03510220049033 · Cited by 1,972
Self-citationBrookmeyer, R., Gray, S., & Kawas, C. (1998) · American Journal of Public Health · doi:10.2105/ajph.88.9.1337 · Cited by 1,787
A Prospective Study of Plasma Homocyst(e)ine and Risk of Myocardial Infarction in US Physicians
Stampfer, M. J. (1992) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1992.03490070059042 · Cited by 1,709
Brain Infarction and the Clinical Expression of Alzheimer Disease<subtitle>The Nun Study</subtitle>
Snowdon, D. A. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03540340047031 · Cited by 1,590
Aging, energy, and oxidative stress in neurodegenerative diseases
Beal, M. F. (1995) · Annals of Neurology · doi:10.1002/ana.410380304 · Cited by 1,440
Research works printed but not linked: 3
- Berg L, 1988, Psychopharmacol Bull, 24, 637
- Levin ML, 1953, Acta Unio Int Contr Cancrum, 9, 531
- 1996, Fed Regist, 61, 8781
Cited by
Items 501–600 of 1,022
Zhang, N., Qu, F., Luo, H. Q., & Li, N. B. (2012) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2012.10.090 · Cited by 105
Ma, F., Wu, T., Zhao, J., Song, A., Liu, H., Xu, W., & Huang, G. (2016) · Scientific Reports · doi:10.1038/srep37486 · Cited by 105
Folate deficiency inhibits proliferation of adult hippocampal progenitors
Kruman, I. I., Mouton, P. R., Emokpae, R., Cutler, R. G., & Mattson, M. P. (2005) · NeuroReport · doi:10.1097/00001756-200507130-00005 · Cited by 105
“Hyperhomocysteinemia has been implicated as a strong, independent risk factor for the development of Alzheimer’s disease [7].”
BackgroundYao, Z., Bai, H., Li, C., & Shi, G. (2011) · Chemical Communications · doi:10.1039/c1cc11990g · Cited by 104
Plant amino acid-derived vitamins: biosynthesis and function
Miret, J. A., & Munné‐Bosch, S. (2013) · Amino Acids · doi:10.1007/s00726-013-1653-3 · Cited by 108
Live cells imaging using a turn-on FRET-based BODIPY probe for biothiols
Su, D., Teoh, C. L., Sahu, S., Das, R. K., & Chang, Y. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.04.035 · Cited by 104
“While Hcy is a risk factor for Alzheimer’s disease and cardiovascular diseases, total plasma Hcy concentrations have been proven to link to birth defects and cognitive impairment at the elderly stage [4].”
BackgroundReliga, D., Styczynska, M., Peplonska, B., Gabryelewicz, T., Pfeffer, A., Chodakowska, M., Luczywek, E., Wasiak, B., Stepien, K., Golebiowski, M., et al. (2003) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000070677 · Cited by 104
Nutrient intake, nutritional status, and cognitive function with aging
Tucker, K. L. (2016) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13062 · Cited by 118
Mechanistic Link between Vitamin B12 and Alzheimer’s Disease
Lauer, A. A., Grimm, H. S., Apel, B., Golobrodska, N., Kruse, L., Ratanski, E., Schulten, N., Schwarze, L., Slawik, T., Sperlich, S., et al. (2022) · Biomolecules · doi:10.3390/biom12010129 · Cited by 138
Alzheimer's disease: How does it start?
de la Torre, J. C. (2002) · Journal of Alzheimer's Disease · doi:10.3233/jad-2002-4606 · Cited by 104
“…of saturated fat [105], presence of APOE4 allele [36,141], transient ischemic attacks [131], depression [58,71], high serum homocysteine levels [59,171], menopause [143,199] high plasma fibrinogen concentrations [3], hemorheologic abnormalities [3,67,177], hypotension [37,135], ischemic stroke…”
DNA damage responses in neural cells: Focus on the telomere
Zhang, P., Dilley, C. M., & Mattson, M. P. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2006.11.052 · Cited by 115
“Data from the Framingham study establishes that elevated plasma homocysteine levels is an independent risk factor for AD (Seshadri et al., 2002).”
BackgroundFolate: A Key to Optimizing Health and Reducing Disease Risk in the Elderly
Rampersaud, G. C., Kauwell, G. P. A., & Bailey, L. B. (2003) · Journal of the American College of Nutrition · doi:10.1080/07315724.2003.10719270 · Cited by 103
“Recently, an evaluation of the Framingham Study cohort found 40% to 80% higher adjusted relative risks for dementia and Alzheimer’s disease, respectively, for each one standard deviation increase in plasma homocysteine as compared to baseline measurements [80].”
MethodS-Adenosylmethionine Is Decreased in the Cerebrospinal Fluid of Patients with Alzheimer’s Disease
Linnebank, M., Popp, J., Smulders, Y. M., Smith, D. E. C., Semmler, A., Farkas, M., Kulic, L., Cvetanovska, G., Blom, H. J., Stoffel‐Wagner, B., et al. (2010) · Neurodegenerative Diseases · doi:10.1159/000309657 · Cited by 111
“Sporadic Alzheimer’s disease (AD) is the most common cause of dementia in the elderly. Known risk factors for AD include age, gender, the presence of the apolipoprotein E 4 (APOE4) allele and increased homocysteine plasma levels [”
BackgroundShi, Q., Savage, J. E., Hufeisen, S. J., Rauser, L., Grajkowska, E., Ernsberger, P. R., Wroblewski, J. T., Nadeau, J. H., & Roth, B. L. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.047092 · Cited by 109
“the risk for AD (Miller, 2000;Seshadri et al., 2002) and schizophrenia (Levine et al, 2002).”
BackgroundInfluentialDysregulation of Epigenetic Mechanisms of Gene Expression in the Pathologies of Hyperhomocysteinemia
Perła‐Kaján, J., & Jakubowski, H. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133140 · Cited by 110
“Cardiovascular disease and stroke [4], dementia [5], schizophrenia [6], infertility, pregnancy complications, birth defects [7], cancer [8,9], liver injury [10], and osteoporosis [11] are all associated with HHcy.”
BackgroundCardiac Disorders as Risk Factors for Alzheimer's Disease
de Toledo Ferraz Alves, T. C., Ferreira, L. K., Wajngarten, M., & Busatto, G. F. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-091561 · Cited by 102
“Although some studies have suggested a graded association between HCY levels and the risk of AD [114], opening a perspective for AD treatment, randomized controlled trials of vitamin B and folate failed to slow cognitive decline in people with either normal or impaired cognition including AD…”
Levodopa-Associated Increase of Homocysteine Levels and Sural Axonal Neurodegeneration
Müller, T. H., Renger, K., & Kuhn, W. (2004) · Archives of Neurology · doi:10.1001/archneur.61.5.657 · Cited by 102
The Role of Homocysteine in Multisystem Age-Related Problems: A Systematic Review
Kuo, H.-K., Sorond, F. A., Chen, J.-H., Hashmi, A., Milberg, W., & Lipsitz, L. A. (2005) · The Journals of Gerontology Series A · doi:10.1093/gerona/60.9.1190 · Cited by 112
“Seshadri and colleagues (86) followed the Framingham Study cohort over a median of 8 years and concluded that an increased plasma homocysteine level is a strong, independent risk factor for the development of dementia and AD.”
BackgroundLamers, Y., Prinz‐Langenohl, R., Moser, R., & Pietrzik, K. F. (2004) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/79.3.473 · Cited by 102
Millard, H. R., Musani, S. K., Dibaba, D. T., Talegawkar, S. A., Taylor, H. A., Tucker, K. L., & Bidulescu, A. (2018) · European Journal of Nutrition · doi:10.1007/s00394-016-1296-8 · Cited by 101
Almeida, O. P., Flicker, L. A., Lautenschlager, N. T., Leedman, P. J., Vasikaran, S. D., & BOCKXMEER, F. M. V. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.03.007 · Cited by 101
“Previous studies, have described that high total plasma Hcy is associated with increased risk of Alzheimer’s disease [11,26] and strokes [20].”
Homocysteine, cerebrovascular disease and brain atrophy
Sachdev, P. S. (2004) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2004.09.006 · Cited by 110
Nutritional factors, cognitive decline, and dementia
Parigi, A. D., Panza, F., Capurso, C. A., & Solfrizzi, V. (2005) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2005.09.020 · Cited by 118
Hyperhomocysteinemia in epileptic patients on new antiepileptic drugs
Belcastro, V., Striano, P., Gorgone, G., Costa, C., Ciampa, C., Caccamo, D., Pisani, L. R., Oteri, G., Marciani, M. G., Aguglia, U., et al. (2010) · Epilepsia · doi:10.1111/j.1528-1167.2009.02303.x · Cited by 107
“In the neurologic field, an increasing body of data has indicated that supraphysiologic Hcy levels are a risk factor for cerebrovascular diseases and brain atrophy (Homocysteine studies collaboration, 2002; Seshadri et al., 2002; Hassan et al., 2004; Ravaglia et al., 2005; Spence, 2007).”
BackgroundSun, J. L., Yang, F., Zhao, D., Chen, C., & Yang, X. (2015) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5b00434 · Cited by 100
A fluorescent probe for relay recognition of homocysteine and Group IIIA ions including Ga( iii )
Wang, Y., Liu, S.-B., Ling, W., & Peng, Y. (2015) · Chemical Communications · doi:10.1039/c5cc07886e · Cited by 100
Fluorescent probes with multiple channels for simultaneous detection of Cys, Hcy, GSH, and H2S
Xu, Z., Qin, T., Zhou, X., Wang, L., & Liu, B. (2019) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2019.115672 · Cited by 103
Prevention and Treatment of Dementia or Alzheimer’s Disease by Statins: A Meta-Analysis
Zhou, B., Teramukai, S., & Fukushima, M. (2007) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000099037 · Cited by 100
Links Between the Pathology of Alzheimer's Disease and Vascular Dementia
Sadowski, M., Pankiewicz, J. E., Scholtzova, H., Li, Y., Quartermain, D., Duff, K., & Wısnıewskı, T. (2004) · Neurochemical Research · doi:10.1023/b:nere.0000023612.66691.e6 · Cited by 115
Lehmann, M., Regland, B., Blennow, K., & Gottfries, C. G. (2003) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000071002 · Cited by 100
The molecular basis of homocysteine thiolactone-mediated vascular disease
Jakubowski, H. (2007) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2007.338 · Cited by 104
“Although severe hyperhomocysteinemia is rare, mild hyperhomocysteinemia is quite prevalent in the general population and is associated with an increased risk of vascular (4) and neurological complications (5), and predicts mortality in heart disease patients (6).”
BackgroundYuan, L., Lin, W., Chen, H., Zhu, S., & He, L. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201303179 · Cited by 98
Stobiecka, M., Deeb, J., & Hepel, M. (2009) · Biophysical Chemistry · doi:10.1016/j.bpc.2009.11.001 · Cited by 105
Hvas, A., Juul, S., Lauritzen, L., Nexø, E., & Ellegaard, J. (2003) · Journal of Affective Disorders · doi:10.1016/s0165-0327(03)00169-1 · Cited by 106
“However, a significant association was found between high P-tHcy and a low CAMCOG score which is in agreement with a recent study concluding that P-tHcy is an independent risk factor for the development of dementia and Alzheimer’s disease (Seshadri et al., 2002).”
ResultFeng, L., Ng, T.-P., Chuah, L., Niti, M., & Kua, E.-H. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/84.6.1506 · Cited by 98
Potential role of dietary n−3 fatty acids in the prevention of dementia and macular degeneration
Johnson, E. J., & Schaefer, E. J. (2006) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.6.1494s · Cited by 115
Devlin, A. M., Clarke, R., Birks, J., Evans, J. G., & Halsted, C. H. (2006) · American Journal of Clinical Nutrition · doi:10.1093/ajcn.83.3.708 · Cited by 109
“Hyperhomocysteinemia is an independent risk factor for cardiovascular disease (1–3), Alzheimer disease (4, 5), cognitive impairment (6), and osteoporotic fractures (7).”
BackgroundShewry, P. R., Piironen, V. I., Lampi, A., Edelmann, M., Kariluoto, S., Nurmi, T., Fernández-Orozco, R., Andersson, A. A. M., Åman, P., Fraś, A., et al. (2010) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf100053d · Cited by 109
Homocysteine and levodopa: Should Parkinson disease patients receive preventative therapy?
Postuma, R. B., & Lang, A. E. (2004) · Neurology · doi:10.1212/01.wnl.0000137886.74175.5a · Cited by 113
Homocysteine Metabolism, Atherosclerosis, and Diseases of Aging
McCully, K. S. (2015) · Comprehensive physiology · doi:10.1002/cphy.c150021 · Cited by 115
Wang, R., Chen, L., Liu, P., Zhang, Q., & Wang, Y. (2012) · Chemistry - A European Journal · doi:10.1002/chem.201200671 · Cited by 97
Wei, C., Liu, X., Gao, Y., Wu, Y., Guo, X., Ying, Y., Wen, Y., & Yang, H. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.8b01974 · Cited by 97
The Structure and Function of Paraoxonase-1 and Its Comparison to Paraoxonase-2 and -3
Taler‐Verčič, A., Goličnik, M., & Bavec, A. (2020) · Molecules · doi:10.3390/molecules25245980 · Cited by 97
In Vitro Effect of Homocysteine on Some Parameters of Oxidative Stress in Rat Hippocampus
STRECK, E. L., Vieira, P. S., Wannmacher, C. M. D., Dutra-Filho, C. S., Wajner, M., & Wyse, Â. T. D. S. (2003) · Metabolic Brain Disease · doi:10.1023/a:1023815119931 · Cited by 97
Highly selective colorimetric sensor for cysteine and homocysteine based on azo derivatives
Zhang, D., Zhang, M., Liu, Z., Yu, M., Li, F., Yi, T., & Huang, C. (2006) · Tetrahedron Letters · doi:10.1016/j.tetlet.2006.07.080 · Cited by 97
Vitamin B12 Status in the Elderly as Judged by Available Biochemical Markers
Obeid, R., Schorr, H., Eckert, R., & Herrmann, W. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2003.021717 · Cited by 97
STRECK, E. L., Matté, C., Vieira, P. S., Rombaldi, F., Wannmacher, C. M. D., Wajner, M., & Wyse, Â. T. D. S. (2002) · Neurochemical Research · doi:10.1023/a:1021670607647 · Cited by 97
Vitamin B12status, cognitive decline and dementia: a systematic review of prospective cohort studies
O'Leary, F., Allman-Farinelli, M., & Samman, S. (2012) · British Journal Of Nutrition · doi:10.1017/s0007114512004175 · Cited by 96
“Seshadri et al.((54)), USA 76 years 38·9 % M 8 years†, range 1–13 years n 932 Dementia Age, sex, apoE genotype Serum vitamin B12 not independently related to the risk of dementia No effect P”
BackgroundMethodBiomarkers of dementia in obstructive sleep apnea
Baril, A., Carrier, J., Lafrenière, A., Warby, S. C., Poirier, J., Osorio, R. S., Ayas, N., Dubé, M., Petit, D., & Gosselin, N. (2018) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2018.08.001 · Cited by 110
Ligthart, S., Richard, E., van Charante, M., & Gool, V. (2010) · Vascular Health and Risk Management · doi:10.2147/vhrm.s7343 · Cited by 96
Hao, W., McBride, A., McBride, S., Gao, J. P., & Wang, Z. Y. (2010) · Journal of Materials Chemistry · doi:10.1039/c0jm02497j · Cited by 98
Life Expectancy With Cognitive Impairment in the Older Population of the United States
Suthers, K., Kim, J. K., & Crimmins, E. (2003) · The Journals of Gerontology Series B: Psychological Sciences and Social Sciences · doi:10.1093/geronb/58.3.s179 · Cited by 96
Agnew-Blais, J. C., Wassertheil-Smoller, S., Kang, J. H., Hogan, P. E., Coker, L. H., Snetselaar, L. G., & Smoller, J. W. (2015) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2014.07.006 · Cited by 95
Yang, Y.-T., Huo, F., Yin, C., Zheng, A., Chao, J., Li, Y., Nie, Z., Martínez‐Máñez, R., & Liu, D. (2013) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2013.03.007 · Cited by 97
“…mercapto biomolecules—cysteine (Cys), homocysteine (Hcy) and glutathione (GSH)—have similar structures and play many crucial roles in physiological matrices (Wu et al., 2012; Shao et al., 2011; Chen et al., 2010; Schulz et al., 2000; Seshadri et al., 2002; Ball et al., 2006; Hong et al., 2006).”
BackgroundVitamin B12 and Homocysteine Levels Predict Different Outcomes in Early Parkinson's Disease
Christine, C. W., Auinger, P., Joslin, A., Yelpaala, Y., Green, R., & on behalf of the Parkinson Study Group—DATATOP Investigators (2018) · Movement Disorders · doi:10.1002/mds.27301 · Cited by 94
“This independent association of tHcy with cognitive outcomes is consistent with other large studies in aging.(34,35) Moreover, it is consistent with findings reported in a small, crosssectional study of treated PD patients.”
ResultFaux, N. G., Ellis, K. A., Porter, L., Fowler, C. J., Laws, S. M., Martins, R. N., Pertile, K. K., Rembach, A., Rowe, C. C., Rumble, R. L., et al. (2011) · Journal of Alzheimer’s Disease · doi:10.3233/jad-2011-110752 · Cited by 95
Rodríguez-Oroz, M. C., Lage, P. M., Sanchez-Mut, J. V., Lamet, I., Pagonabarraga, J., Toledo, J. B., García‐García, D., Clavero, P., Samaranch, L., Irurzun, C., et al. (2009) · Movement Disorders · doi:10.1002/mds.22522 · Cited by 104
Combination of serum markers related to several mechanisms in Alzheimer’s disease
Teunissen, C. E., Lütjohann, D., von Bergmann, K., Verhey, F. R. J., Vreeling, F. W., Wauters, A., Bosmans, E., Bosma, H., van Boxtel, M. P. J., Maes, M. H. J., et al. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(03)00005-8 · Cited by 99
“Lastly, the recently reported evidence for homocysteine as a risk factor for AD indicates a vascular involvement [39].”
BackgroundElias, M. F., Robbins, M. A., Budge, M. M., Elias, P. K., Brennan, S. L., Johnston, C., Nagy, Z., & Bates, C. J. (2006) · Psychosomatic Medicine · doi:10.1097/01.psy.0000221380.92521.51 · Cited by 94
Lo, K. K., & Li, S. P. (2014) · RSC Advances · doi:10.1039/c3ra47611a · Cited by 112
Yolk–Shell Upconversion Nanocomposites for LRET Sensing of Cysteine/Homocysteine
Zhao, L., Peng, J., Chen, M., Liu, Y., Yao, L., Feng, W., & Li, F. (2014) · ACS Applied Materials & Interfaces · doi:10.1021/am501249p · Cited by 94
Kwok, T. C. Y., Wu, Y., Lee, J., Lee, R., Yung, C. Y., Choi, G., Lee, V. W. Y., Harrison, J., Lam, L. C. W., & Mok, V. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2019.11.005 · Cited by 108
Effects of Homocysteine on the Dopaminergic System and Behavior in Rodents
Lee, E., Chen, H., Soliman, K. F. A., & Charlton, C. G. (2005) · NeuroToxicology · doi:10.1016/j.neuro.2005.01.008 · Cited by 97
Homocysteine levels and leukocyte telomere length
Richards, J. B., Valdes, A. M., Gardner, J. P., Kato, B. S., Siva, A., Kimura, M., Lu, X., Mj, B., Aviv, A., & Spector, T. D. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.12.035 · Cited by 100
“In normal subjects without homocystinuria, lasma homocysteine levels are increased in essential ypertension [2], cardiovascular disease (CVD) [3–6], osteoorosis [7] and dementia [8,9].”
BackgroundHematologic manifestations ofHelicobacter pyloriinfection
Campuzano‐Maya, G. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i36.12818 · Cited by 114
Hooshmand, B., Solomon, A., Kåreholt, I., Rusanen, M., Hänninen, T., Leiviskä, J., Winblad, B., Laatikainen, T., Soininen, H., & Kivipelto, M. (2012) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2011.02484.x · Cited by 93
General anesthetic and the risk of dementia in elderly patients: current insights
Seitz, D. P., Hussain, M., Eckenhoff, R. G., & Berger, M. (2014) · Clinical Interventions in Aging · doi:10.2147/cia.s49680 · Cited by 108
Shrivas, K. K., & Wu, H. (2008) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.3681 · Cited by 94
Molecular mechanisms of homocysteine toxicity
Boldyrev, A. A. (2009) · Biochemistry (Moscow) · doi:10.1134/s0006297909060017 · Cited by 107
Protective Mechanisms against Homocysteine Toxicity
Zimny, J., Sikora, M., Guranowski, A., & Jakubowski, H. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603656200 · Cited by 99
Neuroprotective Effects of Garlic A Review
Mathew, B., & Biju, R. S. (2008) · Libyan Journal of Medicine · doi:10.4176/071110 · Cited by 113
“The modified LDL particles tend to aggregate, are endocytosed by macrophages, and increase the tendency for atherogenesis [34].”
BackgroundMei, J., Wang, Y., Tong, J., Wang, J., Qin, A., Sun, J. Z., & Tang, B. Z. (2012) · Chemistry - A European Journal · doi:10.1002/chem.201202969 · Cited by 94
Román, G. C., Páez, O. M., & Bernal, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20020319 · Cited by 103
Andersson, C., Nayor, M. G., Tsao, C. W., Levy, D. A., & Vasan, R. S. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.01.059 · Cited by 123
Green, R., & Miller, J. W. (2005) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2005.183 · Cited by 104
Cacciapuoti, F. (2011) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-011-0550-4 · Cited by 108
“Hyperhomocysteinemia has been also identified as a mediator of other clinical manifestations different from vasculopaties, such as dementia-type disorders [2], Alzheimer disease [3], premature osteoporosis-induced bone fractures [4], mental retardation, and premature diabetic retinopathy [5].”
BackgroundXia, L., Cregan, A. G., Berben, L. A., & Brasch, N. E. (2004) · Inorganic Chemistry · doi:10.1021/ic040022c · Cited by 93
Ellinson, M., Thomas, J., & Patterson, A. (2004) · Journal of Human Nutrition and Dietetics · doi:10.1111/j.1365-277x.2004.00532.x · Cited by 92
Locascio, J. J., Fukumoto, H., Yap, L., Bottiglieri, T., Growdon, J. H., Hyman, B. T., & Irizarry, M. C. (2008) · Archives of Neurology · doi:10.1001/archneur.65.6.776 · Cited by 91
“5) [0-73] ADL at blood drawing 43 (23) [6-87] Biochemical data, mean (SD) [range]b A 40 level, pmol/L 51.”
BackgroundHodgson, N., Trivedi, M., Muratore, C., Li, S., & Deth, R. (2013) · Journal of Alzheimer's Disease · doi:10.3233/jad-130101 · Cited by 91
“Increased plasma HCY is an identified risk factor for AD [28], and hypomethylation of DNA has been observed in the brains of AD patients [13, 16, 27–29].”
Homocysteine Metabolism in ZDF (Type 2) Diabetic Rats
Wijekoon, E. P., Hall, B., Ratnam, S., Brosnan, M. E., Zeisel, S. H., & Brosnan, J. T. (2005) · Diabetes · doi:10.2337/diabetes.54.11.3245 · Cited by 92
“In addition, hyperhomocysteinemia has also been identified as a risk factor for Alzheimer’s disease (2) and osteoporotic fractures (3).”
BackgroundThoughts on B-vitamins and dementia
Morris, M. C., Schneider, J. A., & Tangney, C. C. (2006) · Journal of Alzheimer's Disease · doi:10.3233/jad-2006-9409 · Cited by 91
A series of BODIPY-based probes for the detection of cysteine and homocysteine in living cells
Wang, N., Chen, M., Gao, J.-H., Ji, X., He, J., Zhang, J., & Zhao, W. (2018) · Talanta · doi:10.1016/j.talanta.2018.11.066 · Cited by 91
Chapter 2 Genetics of the Framingham Heart Study Population
Govindaraju, D. R., Cupples, L. A., Kannel, W. B., O’Donnell, C. J., Atwood, L. D., D’Agostino, R. B., Fox, C. S., Larson, M., Levy, D. A., Murabito, J. M., et al. (2008) · Advances in genetics · doi:10.1016/s0065-2660(08)00602-0 · Cited by 108
Self-citationNutrition and prevention of Alzheimer’s dementia
Swaminathan, A., & Jicha, G. A. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00282 · Cited by 136
Hyperhomocysteinemia is associated with cognitive impairment in multiple sclerosis
Russo, C. V., Morabito, F. C., Luise, F., Piromalli, A., Battaglia, L., Vinci, A., Lombardo, V. T., de Marco, V., Morabito, P., Condino, F., et al. (2007) · Journal of Neurology · doi:10.1007/s00415-007-0668-7 · Cited by 97
Treatment of Alzheimer’s Disease with a Cholinesterase Inhibitor Combined with Antioxidants
Cornelli, U. (2010) · Neurodegenerative Diseases · doi:10.1159/000295663 · Cited by 89
Catalytic Mechanism of Glycine N-Methyltransferase,
Takata, Y., Huang, Y., Komoto, J., Yamada, T., Konishi, K., Ogawa, H., Gomi, T., Fujioka, M., & Takusagawa, F. (2003) · Biochemistry · doi:10.1021/bi034245a · Cited by 90
Kand, D., Mishra, P. K., Saha, T., Lahiri, M., & Talukdar, P. (2012) · The Analyst · doi:10.1039/c2an35524h · Cited by 90
Milewicz, A., Gejdel, E., Sworen, H., Sienkiewicz, K., Jedrzejak, J., Teucher, T., & Schmitz, H. (1993) · PubMed · Cited by 145
Mechanistic Link between Vitamin B12 and Alzheimer’s Disease
Lauer, A. A., Grimm, H. S., Apel, B., Golobrodska, N., Kruse, L., Ratanski, E., Schulten, N., Schwarze, L., Slawik, T., Sperlich, S., et al. (2022) · Publications of the UdS (Saarland University) · doi:10.22028/d291-35299 · Cited by 90
The oxidative damage theory of aging
Lin, M. T., & Flint Beal, M. (2003) · Clinical Neuroscience Research · doi:10.1016/s1566-2772(03)00007-0 · Cited by 89
An iminofluorescein-Cu2+ ensemble probe for selective detection of thiols
Wang, H., Zhou, G., & Chen, X. (2012) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2012.10.006 · Cited by 89
Moorthy, D., Peter, I., Scott, T. M., Parnell, L. D., Lai, C., Crott, J. W., Ordovás, J. M., Selhub, J., Griffith, J., Rosenberg, I. H., et al. (2012) · Journal of Nutrition · doi:10.3945/jn.112.161828 · Cited by 100
Self-citationMetabolomics in the Development and Progression of Dementia: A Systematic Review
Jiang, Y., Zhu, Z., Shi, J., An, Y., Zhang, K., Wang, Y., Li, S., Li, J., Ye, W., Cui, M., et al. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00343 · Cited by 94
“Variations in lipid, energy, amino acid, purine, and neurotransmitter metabolism, and oxidative stress were associated with dementia pathogenesis in many previous crosssectional animal models and human patient metabolomics studies (Seshadri et al., 2002; Thambisetty and Lovestone, 2010; Xu et al., 2012; Ahmed et al.,…”
BackgroundHighly luminescent carbon dots as temperature sensors and “off-on” sensing of Hg2+ and biothiols
Zhang, H., You, J., Wang, J., Dong, X., Guan, R., & Cao, D. (2019) · Dyes and Pigments · doi:10.1016/j.dyepig.2019.107950 · Cited by 87
Lee, M. Y., Lee, J.-H., Hyeon, S. J., Cho, H., Hwang, Y. J., Shin, J., McKee, A. C., Kowall, N. W., Kim, J., Stein, T. D., et al. (2020) · Aging Cell · doi:10.1111/acel.13153 · Cited by 90
“Further, elevated plasma homocysteine, which inhibits DNA methylation, has been reported to be a significant risk factor for AD (Ravaglia et al., 2005; Seshadri et al., 2002).”
BackgroundFluorescence probes for thiol-containing amino acids and peptides in aqueous solution
Fu, Y., Li, H., Hu, W., & Zhu, D. (2005) · Chemical Communications · doi:10.1039/b503772g · Cited by 89
Hyperhomocysteinemia among Omani autistic children: a case-control study.
Ali, A., Waly, M. I., Al-Farsi, Y. M., Essa, M. M., Al-Sharbati, M. M., & Deth, R. C. (2011) · Acta Biochimica Polonica · doi:10.18388/abp.2011_2223 · Cited by 89
“Plasma total homocysteine (tHcy) levels could also be associated with rapid cognitive decline and higher behavioral disturbances and depression in Alzheimer disease (Seshadri et al., 2002; Chen et al., 2010; Tu et al., 2010).”
BackgroundConnelly, P., Prentice, N. P., Cousland, G., & Bonham, J. R. (2007) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1856 · Cited by 99
“, 2000), but high HCy levels are associated with an increased risk of Alzheimer’s disease (AD) (Seshadri et al., 2002) in which a negative correlation between HCy levels and Mini-Mental State Examination (MMSE) (Folstein et al.”
Background
Metadata
- Authors
- Seshadri, S., Beiser, A., Selhub, J., Jacques, P. F., Rosenberg, I. H., D'Agostino, R. B., Wilson, P. W. F., & Wolf, P. A.
- Affiliations
- Boston University (US)
- Tufts University (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2002-02-14
- Volume
- 346
- Issue
- 7
- Pages
- 476-483
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2052588755
- Cited by
- 3,237
- References
- 55
- Citations by year
- 2026: 49 · 2025: 61 · 2024: 82 · 2023: 79 · 2022: 90 · 2021: 102 · 2020: 91 · 2019: 133 · 2018: 132 · 2017: 138 · 2016: 138 · 2015: 149 · 2014: 174 · 2013: 154 · 2012: 155
- FWCI
- 111.96
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (n01hc038038-022)
- National Institute on Aging (5R01 AG 08122-11, 5R01-AG16495-02, R01AG016495, R01AG008122)
- National Heart, Lung, and Blood Institute (N01-HC-38038)
- National Institute of Neurological Disorders and Stroke (5R01 NS 17950-19, R01NS017950)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Folate and B Vitamins Research
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- plasma homocysteine, dementia, Alzheimer's disease, risk factors, newly diagnosed dementia, folic acid, vitamin B12, vitamin B6, apolipoprotein E, Framingham Heart Study, cognitive decline
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Apolipoproteins E, Dementia, Female, Homocysteine, Humans, Male, Risk Factors, Cohort Studies, Confounding Factors, Epidemiologic, Multivariate Analysis, Proportional Hazards Models, Hyperhomocysteinemia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.